Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BLU-222 |
Trade Name | |
Synonyms | BLU 222|BLU222 |
Drug Descriptions |
BLU-222 selectively inhibits CDK2, potentially leading to inhibition of cell growth and decreased tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2306). |
DrugClasses | CDK2 Inhibitor 31 |
CAS Registry Number | NA |
NCIT ID | C188045 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BLU-222 | BLU-222 | 0 | 0 |
BLU-222 + Carboplatin | BLU-222 Carboplatin | 0 | 1 |
BLU-222 + Fulvestrant | BLU-222 Fulvestrant | 0 | 1 |
BLU-222 + Fulvestrant + Ribociclib | BLU-222 Fulvestrant Ribociclib | 0 | 1 |